D-0567-2022 Class II Terminated

Recalled by ANI Pharmaceuticals, Inc. — Baudette, MN

FDA drug recall D-0567-2022 was initiated by ANI Pharmaceuticals, Inc. on Feb 15, 2022 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Oct 25, 2022). Affected quantity: 70,788 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 23, 2022
Initiation Date
Feb 15, 2022
Termination Date
Oct 25, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
70,788 bottles

Product description

Alprazolam Tablets, USP 2.0 mg, packaged in a) 100-count bottles (NDC 67253-903-10), b) 500-count bottles (NDC 67253-903-50), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977

Reason for recall

cGMP Deviations

Distribution pattern

Nationwide within the United States

Code information

Lot #: a) 19C002A, Exp. Date 03/2022; 19E012A, 19E013A, Exp. Date 05/2022. b) 19C100B, Exp. Date 04/2022; 19E001B, 19E002B, Exp. Date 05/2022.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0567-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0567-2022. Report a data issue: hello@regdatalab.com.